LENZ Therapeutics, Inc. (LENZ) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $21.54M | +92.0% |
| 2024 | $11.22M | -43.0% |
| 2023 | $19.70M | -23.1% |
| 2022 | $25.61M | +42.8% |
| 2021 | $17.94M | -44.6% |
| 2020 | $32.36M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $21.54M | +92.0% |
| 2024 | $11.22M | -43.0% |
| 2023 | $19.70M | -23.1% |
| 2022 | $25.61M | +42.8% |
| 2021 | $17.94M | -44.6% |
| 2020 | $32.36M | — |